Novo Nordisk A/S’s new Wegovy obesity pill fueled sales in the first quarter and the drugmaker said this year’s declines ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

In France, Wegovy is prescribed as a second-line treatment for obesity, not for people with a lower body mass index (BMI) or ...

Scientists have uncovered a surprising secret hidden inside fat cells that could reshape how we think about obesity and metabolic disease. A protein called HSL, long believed to simply release stored ...

A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...

Illustration of human lymphocytes. (Ruslanas Baranauskas/Science Photo Library) Defeating obesity is rarely easy. For many ...

Can weight loss reverse heart failure? A new study shows that heart muscle cells regain strength and muscle contractions ...

The study, published in Nature Medicine, shows that future risk of 18 obesity-related diseases can be predicted using 20 ...

Childhood obesity remains a major health challenge, and effective interventions often depend on more than nutritional advice ...

Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.